Article tools
  • View PDF
  • Cite this article
  • E-mail this article
  • Send a letter
  • Information on reuse
  • Standard abbreviations
  • Article usage
Author information
Need help?


Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy

Waleed M. Abuzeid, Xiaoling Jiang, Guoli Shi, Hui Wang, David Paulson, Koji Araki, David Jungreis, James Carney, Bert W. O’Malley, Jr. and Daqing Li

Published November 1, 2012

Original citation: J. Clin. Invest. 2009;119(7):1974–1985. doi:10.1172/JCI33816.

Citation for this corrigendum: J. Clin. Invest. 2012;122(11):4300. doi:10.1172/JCI66810.

In Figure 6A, the representative PNA FISH stain images for the “Cisplatin” and “Cisplatin + DL312” groups were identical. The correct figure is below.

The authors regret the error.